Track VITA 34 AG — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

VITA 34 AG V3V.DE · Stock Open VITA 34 AG in new tab

3.50 EUR
EPS
-0.26
P/B
9.89
ROE
-56.80
Beta
0.63
Loading chart...
Key Metrics
EPS-0.26
Book Value0.37
Price to Book9.89
Debt/Equity528.45
% Insiders72.000%
Growth
Revenue Growth-0.03%
Estimates
Forward P/E60.50
Forward EPS0.06

DCF Valuation

Tweak assumptions to recompute fair value for VITA 34 AG (V3V.DE)
Currency: EUR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

VITA 34 AG Logo VITA 34 AG Analysis (V3V.DE)

Germany Health Care Official Website Stock

Is VITA 34 AG a good investment? VITA 34 AG (V3V.DE) is currently trading at 3.50 EUR.

Investor FAQ

Does VITA 34 AG pay a dividend?

No, it does not currently pay a dividend.

What asset class is VITA 34 AG?

VITA 34 AG is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable products. In addition, it engages in research and development, storage, and cryopreservation of sperm and oocytes for use in reproductive medicine; and the manufacturing and distribution of medical devices. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is headquartered in Leipzig, Germany.

Exchange Ticker
GER (Germany) V3V.DE
Trades
Dividend History paid per year (EUR)
Historical Dividends
Year Total Dividends
2019
0.16 EUR
June 7, 2019 0.1600
2018
0.16 EUR
May 18, 2018 0.1600
2017
0.16 EUR
June 29, 2017 0.1556
2016
0.16 EUR
Aug. 26, 2016 0.1556
2015
0.15 EUR
July 29, 2015 0.1458
Stock Splits
Split Date Split Ratio to 1
July 14, 2017 1.030000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion